Related Experiment Video
Updated: Jul 18, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Toll-like receptor 2 does not contribute to host response during postinfluenza pneumococcal pneumonia
Mark C Dessing1, Koenraad F van der Sluijs, Sandrine Florquin
1Center for Infection and Immunity Amsterdam (CINIMA), Laboratory of Experimental Immunology, Department of Pulmonology, University of Amsterdam, The Netherlands. m.c.dessing@amc.uva.nl
Abstract:
Influenza A can be complicated by secondary bacterial pneumonia, which is most frequently caused by Streptococcus pneumoniae and associated with uncontrolled pulmonary inflammation. Evidence points to Toll-like receptor (TLR) 2 as a possible mediator of this exaggerated lung inflammation: (1) TLR2 is the most important "sensor" for gram-positive stimuli, (2) TLR2 contributes to S. pneumoniae-induced inflammation, and (3) influenza A enhances TLR2 expression in various cell types. Therefore, the objective of this study was to determine the role of TLR2 in the host response to postinfluenza pneumococcal pneumonia. TLR2 knockout (KO) and wild-type (WT) mice were infected intranasally with influenza A virus. Fourteen days later they were administered with S. pneumoniae intranasally. Influenza was associated with a similar transient weight loss in TLR2 KO and WT mice. Both mouse strains were fully recovered and had completely cleared the virus at Day 14. Importantly, no differences between TLR2 KO and WT mice were detected during postinfluenza pneumococcal pneumonia with respect to bacterial growth, lung inflammation, or cytokine/chemokine concentrations, with the exception of lower pulmonary levels of cytokine-induced neutrophil chemoattractant in TLR2 KO mice. Toll-like receptor 2 does not contribute to host defense during murine postinfluenza pneumococcal pneumonia.
Insights
Toll-like receptor 2 (TLR2) does not impact host defense against secondary Streptococcus pneumoniae pneumonia following influenza A infection in mice. This suggests TLR2 is not a critical mediator in this complex respiratory infection model.
Area of Science:
- Immunology
- Microbiology
- Pulmonology
Background:
- Influenza A infections can lead to secondary bacterial pneumonia, often caused by Streptococcus pneumoniae.
- Uncontrolled pulmonary inflammation is a hallmark of severe post-influenza pneumonia.
- Toll-like receptor 2 (TLR2) is implicated as a potential mediator of exaggerated lung inflammation due to its role in sensing gram-positive bacteria and its upregulation during influenza.
Purpose of the Study:
- To investigate the role of TLR2 in the host immune response to secondary bacterial pneumonia after influenza A infection.
- To determine if TLR2 deficiency affects bacterial clearance, lung inflammation, or cytokine profiles in a murine model of post-influenza pneumococcal pneumonia.
Main Methods:
- Utilized a murine model involving intranasal inoculation with influenza A virus followed by Streptococcus pneumoniae.
- Employed TLR2 knockout (KO) and wild-type (WT) mice to compare host responses.
- Assessed bacterial load, lung inflammation markers, and cytokine/chemokine concentrations.
Main Results:
- Both TLR2 KO and WT mice experienced similar transient weight loss during influenza A infection and fully recovered by day 14.
- No significant differences were observed between TLR2 KO and WT mice in bacterial growth, overall lung inflammation, or most cytokine/chemokine levels during the secondary pneumococcal pneumonia phase.
- A minor reduction in pulmonary cytokine-induced neutrophil chemoattractant was noted in TLR2 KO mice.
Conclusions:
- Toll-like receptor 2 does not play a significant role in host defense against Streptococcus pneumoniae pneumonia complicating influenza A infection in mice.
- The findings suggest that TLR2 is not a critical therapeutic target for mitigating inflammation in this specific post-influenza bacterial pneumonia model.
More Related Videos
07:07Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice
Published on: June 27, 2020
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Related Concept Videos
Pneumonia II: Pathophysiology
Respiratory Syncytial Virus Disease
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...